PAS-004 is being tested in a phase 1 trial for MAPK pathway-driven advanced solid tumors, with dosing initiated at 30 mg. The trial is multicenter, open-label, and dose-escalation, assessing safety, ...
The field of plant stress biology has become increasingly crucial as climate change drives heightened frequencies and severities of abiotic stresses such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results